Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acutus Medical Inc AFIB

Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or... see more

Recent & Breaking News (OTCPK:AFIB)

Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results

GlobeNewswire April 20, 2023

RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy

GlobeNewswire April 20, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 3, 2023

Sidoti's Small-Cap Virtual March Conference

Accesswire March 20, 2023

Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 16, 2023

Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 9, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 1, 2023

Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences

Accesswire February 14, 2023

Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter

GlobeNewswire February 6, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 1, 2023

Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer

GlobeNewswire January 9, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 3, 2023

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium

GlobeNewswire December 29, 2022

Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

GlobeNewswire December 21, 2022

Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5

GlobeNewswire December 19, 2022

Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter

GlobeNewswire December 6, 2022

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 1, 2022

Acutus Medical Reports Third Quarter 2022 Financial Results

GlobeNewswire November 10, 2022

Acutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to Medtronic

GlobeNewswire November 3, 2022

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 1, 2022